Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews' Q3 Revenues Dip on Lower Licensing Revenues

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews reported after the close of the market Monday that its third-quarter revenues dropped more than 50 percent on lower licensing revenue year over year.

The Toronto-based firm brought in total revenues of C$166,515 (US$163,309) for the three-month period ended Sept. 30, compared to C$362,964 for the third quarter of 2009. Its license revenue declined to C$162,619 from C$311,684 year over year.

GeneNews' net loss for the quarter was C$1.1 million, or C$.02, compared to a net loss of C$1.4 million, or C$.02 per share, for Q3 2009.

Its R&D spending declined to C$414,966 from C$613,540, and its SG&A expenses dropped to C$374,382 from C$513,495.

The firm sells its ColonSentry genetic test for colorectal cancer in Canada, and it is preparing for a launch of the test in the US and Asia.

Last week, GeneNews raised C$2.1 million in two concurrent private placements aimed at supporting sales and marketing of ColonSentry.

GeneNews finished the quarter with C$477,510 in cash and cash equivalents, C$485,691 in restricted cash, and C$350,080 in short-term investments.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.